Catalent Inc (CTLT)
56.32
-0.21
(-0.37%)
USD |
NYSE |
May 08, 13:57
Catalent Total Assets (Quarterly): 9.988B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.988B |
| September 30, 2023 | 10.02B |
| June 30, 2023 | 10.78B |
| March 31, 2023 | 10.83B |
| December 31, 2022 | 11.15B |
| September 30, 2022 | 10.20B |
| June 30, 2022 | 10.51B |
| March 31, 2022 | 10.32B |
| December 31, 2021 | 10.20B |
| September 30, 2021 | 10.18B |
| June 30, 2021 | 9.112B |
| March 31, 2021 | 8.769B |
| December 31, 2020 | 8.198B |
| September 30, 2020 | 7.984B |
| June 30, 2020 | 7.777B |
| March 31, 2020 | 7.080B |
| December 31, 2019 | 6.195B |
| September 30, 2019 | 6.120B |
| June 30, 2019 | 6.184B |
| March 31, 2019 | 4.493B |
| December 31, 2018 | 4.442B |
| September 30, 2018 | 4.500B |
| Date | Value |
|---|---|
| June 30, 2018 | 4.531B |
| March 31, 2018 | 4.554B |
| December 31, 2017 | 4.387B |
| September 30, 2017 | 3.785B |
| June 30, 2017 | 3.454B |
| March 31, 2017 | 3.285B |
| December 31, 2016 | 3.154B |
| September 30, 2016 | 3.128B |
| June 30, 2016 | 3.091B |
| March 31, 2016 | 3.058B |
| December 31, 2015 | 3.035B |
| September 30, 2015 | 3.056B |
| June 30, 2015 | 3.138B |
| March 31, 2015 | 2.974B |
| December 31, 2014 | 3.038B |
| September 30, 2014 | 2.951B |
| June 30, 2014 | 3.090B |
| March 31, 2014 | 3.091B |
| December 31, 2013 | 3.073B |
| September 30, 2013 | 3.042B |
| June 30, 2013 | 2.950B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.120B
Minimum
Sep 2019
11.15B
Maximum
Dec 2022
9.032B
Average
9.988B
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 63.94B |
| Merck & Co Inc | 105.85B |
| Elanco Animal Health Inc | 14.36B |
| Amgen Inc | 92.98B |
| Avrobio Inc | 101.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.301B |
| Shareholders Equity (Quarterly) | 3.687B |
| Debt to Equity Ratio | 1.358 |
| Current Ratio | 2.481 |
| Net Debt Paydown Yield | -1.97% |